Associate Professor Tim Sprosen
Contact information
| tim.sprosen@ndph.ox.ac.uk | |
| Tel | +44 (0)1865 743604 |
My connections
- UK Biobank Member of Steering Committee
- New York University Abu Dhabi Member of International Advisory Committee for Abu Dhabi Cohort Study
- North-West (Haydock) NHS Research Ethics Committee Chair
- MoreTrials Campaign Coordinator of campaign to make it much easier to do randomised trials
- Participant Panel Research Group
- Research Regulation Research Group
Tim Sprosen
BSc(Hons) DPhil
Associate Professor & Head of Communications, Regulation & Knowledge Transfer
Tim Sprosen is an Associate Professor in the Nuffield Department of Population Health at the University of Oxford.
He studied Pharmacology at Dundee (1983-1987) and Cambridge (1987-1990).
He has spent his entire career in medical research in industry (Renal Division, Baxter Healthcare), public office (Medical Research Council Head Office) and in academia (Cambridge, Oxford, Manchester and Imperial College London). From 2004-2011, he was Chief Scientist at UK Biobank.
His main interests are in the design and execution of large-scale epidemiological studies, public participation in research, the use of health-records in research and promoting appropriate and proportionate governance of research.
He is leading a new public campaign, MoreTrials, working with leading trialists around the world and Sense About Science to make it much easier to do randomised trials. Its goal is to replace the ICH-Good Clinical Practice guideline (which is neither good or about clinical practice) with a new one that will focus on those few things that matter when doing a trial and which is developed by everybody in the trial community (including participants, who ICH still calls "subjects").
Recent Publications
5-
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.
Sudlow C. et al, (2015), PLoS Med, 12
-
UK Biobank: Current status and what it means for epidemiology
Allen N. et al, (2012), Health Policy and Technology, 1, 123 - 126
-
New models for large prospective studies: is there a better way?
Manolio TA. et al, (2012), Am J Epidemiol, 175, 859 - 866
-
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies
Fortier I. et al, (2010), Int J Epidem, 39, 1383 - 1393